Billy James Poteet is a pharmacist who is specialized in Geriatric in Lubbock, Texas. Patients can reach him at 5234 89th St, Lubbock or contact him on 806-798-1021. Active license number of Billy James Poteet is 17988 for Geriatric in Texas. Billy James Poteet is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Billy James Poteet speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Billy James Poteet
Specialization:
Geriatric
Credentials:
R.PH.
Gender:
Male
Location:
5234 89th St, Lubbock, Texas, 79424-3548
Phone:
806-798-1021
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Billy James Poteet are as mentioned below.
NPI Number:
1497378673
NPI Enumeration Date:
22 May, 2020
NPI Last Update On:
22 May, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Billy James Poteet are as mentioned below.
Specialization
License Number
State
Status
Geriatric
17988
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5234 89th St, Lubbock, Texas
Zip:
79424-3548
Phone Number:
806-798-1021
Fax Number:
--
Patients can reach Billy James Poteet at 5234 89th St, Lubbock, Texas or can call on phone at 806-798-1021.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.